Form 8-K - Current report:
SEC Accession No. 0001193125-25-140810
Filing Date
2025-06-13
Accepted
2025-06-13 16:39:10
Documents
12
Period of Report
2025-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d928055d8k.htm   iXBRL 8-K 34222
  Complete submission text file 0001193125-25-140810.txt   152716

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA whwk-20250611.xsd EX-101.SCH 2878
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE whwk-20250611_lab.xml EX-101.LAB 18758
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE whwk-20250611_pre.xml EX-101.PRE 11729
14 EXTRACTED XBRL INSTANCE DOCUMENT d928055d8k_htm.xml XML 3788
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 251047233
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)